Testing effectiveness (Phase 2)Study completedNCT02927184
What this trial is testing
Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease
Who this might be right for
HyperlipidemiaNAFLD
Viking Therapeutics, Inc. 59